from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2540c/aroF

LFCtreatmentdescriptionclass of inhibitor

-0.360

Amikacinug/mL Amikacintranslation

-0.566

Cap5-10ug/mL Capreomycintranslation

0.074

Rox10-50 ug/mL Roxithromycintranslation

0.164

SM2-5 ug/mL Streptomycintranslation

0.175

Tet5-10 ug/mL Tetracyclinetranslation

-0.491

Rif0.2-5ug/mL Rifampicintranscription

-1.071

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.202

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.540

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.291

CPZ10-50 ug/mL Chlorpromazinerespiration

0.883

Clofazimine10-13 ug/mL Clofaziminerespiration

0.169

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.983

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.831

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.250

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.076

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.049

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.117

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.280

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.969

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.667

KCN5-20 ug/mL Potassium cyaniderespiration

-0.004

NaN30.2-2 mM Sodium aziderespiration

0.684

Nigericin50 uM Nigericinrespiration

-1.031

TRC10-150 ug/mL Triclosanrespiration

-0.398

TRZ10-25 ug/mL Thioridazinerespiration

1.086

Valinomycin0.5-10 uM Valinomycinrespiration

-1.213

ZnSO42 mM ZnSO4respiration

-0.576

menadione6-10 ug/mL Menadionerespiration

-0.289

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.075

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.136

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.104

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.857

NRP_1Non-replicating persistence stage 1dosRassociated

0.195

Amp0.2mg/mL AmpicillincellWall

-0.279

Cephalexin20-100 ug/mL CephalexincellWall

-0.190

Cerulenin0.32-5 ug/mL CerulenincellWall

0.001

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.082

EMB10-20 ug/mL EthambutolcellWall

0.057

Eta12-40 ug/mL EthionamidecellWall

-0.058

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.283

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.376

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.384

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.248

BZA0.12 mg/mL BenzamidearomaticAmides

0.266

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.597

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.389

H2O24 mM hydrogen peroxideDNAdamaging

-0.307

Levo10 ug/mL LevofloxacinDNAdamaging

0.267

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.517

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.001

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.402

UVUV-irradiationDNAdamaging

-0.374

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.236

Antimycin12.5-50 ug/mL Antimycin A?

-0.230

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.406

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.867

PA_2110-50 ug/mL Antitubercular compound PA-21?

3.539

PA8240.2-2 ug/mL PA-824?

0.547

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.254

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.334

Verapamil50 uM Verapamil?

-1.468

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.654

methoxatin10-20 ug/mL Methoxatin?